Current and historical daily PE Ratio for Aptahem AB (
XSAT:APTA
) from 2015 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aptahem AB stock (XSAT:APTA) PE ratio as of Jun 19 2024 is 0.
More Details
Aptahem AB (XSAT:APTA) PE Ratio (TTM) Chart
Aptahem AB (XSAT:APTA) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1294
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Aptahem AB PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | At Loss | 2024-04-12 | At Loss |
2024-06-18 | At Loss | 2024-04-11 | At Loss |
2024-06-17 | At Loss | 2024-04-10 | At Loss |
2024-06-14 | At Loss | 2024-04-09 | At Loss |
2024-06-13 | At Loss | 2024-04-08 | At Loss |
2024-06-12 | At Loss | 2024-04-05 | At Loss |
2024-06-11 | At Loss | 2024-04-04 | At Loss |
2024-06-10 | At Loss | 2024-04-03 | At Loss |
2024-06-07 | At Loss | 2024-04-02 | At Loss |
2024-06-05 | At Loss | 2024-03-28 | At Loss |
2024-06-04 | At Loss | 2024-03-27 | At Loss |
2024-06-03 | At Loss | 2024-03-26 | At Loss |
2024-05-31 | At Loss | 2024-03-25 | At Loss |
2024-05-30 | At Loss | 2024-03-22 | At Loss |
2024-05-29 | At Loss | 2024-03-21 | At Loss |
2024-05-28 | At Loss | 2024-03-20 | At Loss |
2024-05-27 | At Loss | 2024-03-19 | At Loss |
2024-05-24 | At Loss | 2024-03-18 | At Loss |
2024-05-23 | At Loss | 2024-03-15 | At Loss |
2024-05-22 | At Loss | 2024-03-14 | At Loss |
2024-05-21 | At Loss | 2024-03-13 | At Loss |
2024-05-20 | At Loss | 2024-03-12 | At Loss |
2024-05-17 | At Loss | 2024-03-11 | At Loss |
2024-05-16 | At Loss | 2024-03-08 | At Loss |
2024-05-15 | At Loss | 2024-03-07 | At Loss |
2024-05-14 | At Loss | 2024-03-06 | At Loss |
2024-05-13 | At Loss | 2024-03-05 | At Loss |
2024-05-10 | At Loss | 2024-03-04 | At Loss |
2024-05-08 | At Loss | 2024-03-01 | At Loss |
2024-05-07 | At Loss | 2024-02-29 | At Loss |
2024-05-06 | At Loss | 2024-02-28 | At Loss |
2024-05-03 | At Loss | 2024-02-27 | At Loss |
2024-05-02 | At Loss | 2024-02-26 | At Loss |
2024-04-30 | At Loss | 2024-02-23 | At Loss |
2024-04-29 | At Loss | 2024-02-22 | At Loss |
2024-04-26 | At Loss | 2024-02-21 | At Loss |
2024-04-25 | At Loss | 2024-02-20 | At Loss |
2024-04-24 | At Loss | 2024-02-19 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
Aptahem AB (XSAT:APTA) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Aptahem AB
ISIN : SE0006543450
Compare
Compare
Traded in other countries / regions
APTA.Sweden IPO Date
2015-04-17Description
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.